<DOC>
	<DOCNO>NCT01291160</DOCNO>
	<brief_summary>This multicenter , prospective , parallel , double-blinded , validation study 12 week duration evaluate safety effectiveness EPIFLO treatment Diabetic Foot Ulcer . The primary objective study : 1 ) evaluate effectiveness EPIFLO combination standard wound therapy wound heal compare standard wound therapy alone ; 2 ) Screening potential safety issue . Diabetic subject Diabetic Foot Ulcer present minimum 30 day enrol . All subject enrol study receive standard wound therapy regimen consist , wound cleansing , moist wound care , off-loading appropriate , aggressive debridement . Subjects randomized either Treatment arm Control arm . Subjects assess weekly sign wound heal 12-week Treatment Period , two week wound closure end 12-week durability Period .</brief_summary>
	<brief_title>Transdermal Continuous Oxygen Therapy Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Male female patient 2090 year age type 1 type 2 diabetes mellitus nonhealing , fullthickness , University Texas Classification Diabetic Foot Ulcers Class IA diabetic foot ulcer least 4 week duration , great 52 week , measure 1 10 cm2 area ( Area = length x width ) 50 % least 65+ age group Any diabetic foot ulcer malleoli Patients partial amputation &amp; include TMA Subjects ; 2090 year age diabetic foot ulcer ; 50 % least 65+ age group Subjects must wind open least 4 week day one screening visit . Subjects wound must ≥1 cm2 size screen visit , great 10 cm2 . Subject 's ABI ≥ 0.7 study limb transcutaneous partial pressure oxygen ( TcpO2 ) &gt; 40mmHg ; toe pressure ≥40mmHg ; Doppler waveform consistent adequate flow foot ( biphasic triphasic waveform ) screen No active malignancy except nonmelanoma skin cancer Subject and/or caregiver must willing able learn perform duty dress change , demonstrate ability . If patient history alcohol substance abuse within 6 month prior base line period , provide proof treatment . Wounds duration &gt; 52 week Evidence gangrene part affect limb ; Subjects active Charcot 's foot study limb ; Subjects schedule undergo vascular surgery , angioplasty thrombolysis ; Subjects infect target ulcer , accompany cellulitis , know suspected osteomyelitis , clinical evidence infection ; Index ulcer expose tendon , ligament , muscle , bone . ulcer present toe Target limb infect begin study Must never malignancy study limb Oral , IV antibiotic/antimicrobial agent medication use within 2 day ( 48 hour ) baseline . Patients steroids &gt; 7mg dosage exclude Subject receive growth factor therapy ( e.g. , autologous plateletrich plasma gel , becaplermin , bilayered cell therapy , dermal substitute , extracellular matrix ) within two week screen date . Subject may pregnant time treatment . Subjects ulcer total Surface Area great 10 cm2 Screening Visit measure member study staff ; Subject undergo renal dialysis , know immune insufficiency , Diabetes Mellitus Ulcers decrease area &gt; 30 % screen 1week runin period History peripheral vascular repair within 30 day baseline . Subject currently receive receive radiation chemotherapy within 3 month randomization . No know `` patientreported '' alcohol substance abuse within three month prior baseline . Subject currently enrol participate within 30 day baseline another investigational device , drug biological trial . Subject allergic broad spectrum primary &amp; secondary dressing material , include occlusive dressing adhesives dressing . Subject Chopart amputation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>